Most Profitable Cancer Fighters Companies

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Net Income
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Net IncomeEfficiencyMarket RiskExp Return
1REGN Regeneron Pharmaceuticals
3.95 B
(0.28)
 1.95 
(0.55)
2BDX Becton Dickinson and
1.71 B
(0.01)
 1.16 
(0.01)
3HALO Halozyme Therapeutics
281.59 M
 0.04 
 3.58 
 0.16 
4ARRY Array Technologies
137.24 M
 0.05 
 5.83 
 0.27 
5HCM HUTCHMED DRC
100.78 M
(0.19)
 3.11 
(0.58)
6PBYI Puma Biotechnology
21.59 M
 0.04 
 5.52 
 0.24 
7TGTX TG Therapeutics
12.67 M
 0.09 
 4.53 
 0.42 
8CTMX CytomX Therapeutics
(569 K)
(0.09)
 4.67 
(0.41)
9MGNX MacroGenics
(9.06 M)
(0.08)
 3.93 
(0.33)
10BYSI BeyondSpring
(21.03 M)
(0.10)
 4.10 
(0.40)
11XBIT XBiotech
(24.56 M)
(0.16)
 5.80 
(0.93)
12RIGL Rigel Pharmaceuticals
(25.09 M)
 0.10 
 7.28 
 0.73 
13CRVS Corvus Pharmaceuticals
(27.03 M)
(0.07)
 6.46 
(0.42)
14NCNA NuCana PLC
(27.63 M)
(0.17)
 4.06 
(0.70)
15CRIS Curis Inc
(47.41 M)
(0.09)
 6.46 
(0.59)
16ANTX AN2 Therapeutics
(64.73 M)
 0.07 
 5.14 
 0.38 
17MESO Mesoblast
(87.96 M)
 0.16 
 7.75 
 1.25 
18HRTX Heron Therapeuti
(110.56 M)
 0.01 
 7.35 
 0.09 
19ADAP Adaptimmune Therapeutics Plc
(113.87 M)
(0.08)
 5.10 
(0.43)
20CLLS Cellectis SA
(116.83 M)
(0.03)
 6.42 
(0.17)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors. Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY